Knowledge Center

Article / Mar 08, 2017

Expanding the Commercial Options

Authors:
  • Marcio Temtem
  • Joao Vicente
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017

Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. ËÄÉ«AV, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.

Related links

Also in the Knowledge Center

Related Content

Chromatography

ËÄÉ«AV has expanded its purification technologies to include chromatography to support development from lab to commercial scale.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, ËÄÉ«AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Technologies

We offer a number of innovative particle engineering technologies, at all scales, to address recent challenges in drug delivery.

Page
Read more